Just backing up my last post, concerning $$$$$$.
The following link gives details of a $420m
license agreement released just in the last week for a Phase 2 DARPin protein to treat retinal diseases.
If PYCs CD40L program was at phase 2 clinical trials, the price tag may be closer to $400m.
ST
http://www.zenopa.com/news/800523681/Allergan_licenses_retinal_disease_drug_from_Molecular_Partners
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.000(0.00%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 420 | 1 |
View Market Depth
| Last trade - 07.03am 16/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |
Day chart unavailable